Camilo C. Roa

655 total citations
14 papers, 188 citations indexed

About

Camilo C. Roa is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Camilo C. Roa has authored 14 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 4 papers in Physiology. Recurrent topics in Camilo C. Roa's work include SARS-CoV-2 and COVID-19 Research (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Camilo C. Roa is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers) and Vaccine Coverage and Hesitancy (3 papers). Camilo C. Roa collaborates with scholars based in Philippines, South Korea and Malaysia. Camilo C. Roa's co-authors include Aziah Ahmad Mahayiddin, Dirk Bredenbröker, Teresita S. de Guia, Han‐Pin Kuo, David S.C. Hui, Vincent M. Balanag, David Price, Hilary Pinnock, Sang‐Heon Cho and Ralf Clemens and has published in prestigious journals such as CHEST Journal, The Journal of Infectious Diseases and European Respiratory Journal.

In The Last Decade

Camilo C. Roa

13 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camilo C. Roa Philippines 6 64 41 31 28 23 14 188
Mohsen Amini Iran 14 55 0.9× 33 0.8× 25 0.8× 43 1.5× 38 1.7× 38 605
Renata Costa Fortes Brazil 13 42 0.7× 70 1.7× 34 1.1× 45 1.6× 43 1.9× 91 392
Hassan Yarmohammadi Iran 10 39 0.6× 28 0.7× 55 1.8× 30 1.1× 10 0.4× 33 368
Danuta Gajewska Poland 11 25 0.4× 52 1.3× 55 1.8× 26 0.9× 24 1.0× 56 363
Filippo Brocadello Italy 10 56 0.9× 44 1.1× 49 1.6× 23 0.8× 6 0.3× 15 301
Biju John India 9 47 0.7× 54 1.3× 18 0.6× 79 2.8× 46 2.0× 23 496
Guilherme Becker Sander Brazil 10 33 0.5× 24 0.6× 27 0.9× 29 1.0× 21 0.9× 30 360
M. G. Gentile Italy 11 23 0.4× 84 2.0× 64 2.1× 23 0.8× 28 1.2× 28 403
Afshin Safaei Asl Iran 11 47 0.7× 26 0.6× 10 0.3× 33 1.2× 46 2.0× 33 322
Mordechai Bulkowstein Israel 9 34 0.5× 21 0.5× 14 0.5× 35 1.3× 25 1.1× 10 344

Countries citing papers authored by Camilo C. Roa

Since Specialization
Citations

This map shows the geographic impact of Camilo C. Roa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilo C. Roa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilo C. Roa more than expected).

Fields of papers citing papers by Camilo C. Roa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilo C. Roa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilo C. Roa. The network helps show where Camilo C. Roa may publish in the future.

Co-authorship network of co-authors of Camilo C. Roa

This figure shows the co-authorship network connecting the top 25 collaborators of Camilo C. Roa. A scholar is included among the top collaborators of Camilo C. Roa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilo C. Roa. Camilo C. Roa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Quiambao, Beatriz P., Camilo C. Roa, Charissa Borja-Tabora, et al.. (2024). A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies. Vaccine. 42(22). 126018–126018. 4 indexed citations
2.
Hannawi, Suad, Xiaohong Wu, Ralph Elvi Villalobos, et al.. (2024). Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial. Med. 5(10). 1282–1292.e3. 4 indexed citations
3.
Aziz, Asma Binte, Jonathan D. Sugimoto, Young Ae You, et al.. (2024). Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: A cluster randomised analysis. Journal of Infection. 89(4). 106260–106260. 1 indexed citations
4.
Roa, Camilo C., Eric Plennevaux, Igor Smolenov, et al.. (2024). SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines. Human Vaccines & Immunotherapeutics. 20(1). 2301632–2301632. 2 indexed citations
5.
Roa, Camilo C., Eric Plennevaux, Igor Smolenov, et al.. (2023). Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults. The Journal of Infectious Diseases. 228(9). 1253–1262. 4 indexed citations
6.
Fernandez, Lenora, et al.. (2021). Philippine Normal Reference Values for Cardiopulmonary Exercise Testing. 9(2). 70–70. 1 indexed citations
7.
Chisholm, Alison, David Price, Hilary Pinnock, et al.. (2017). Personalising care of adults with asthma from Asia: a modified e-Delphi consensus study to inform management tailored to attitude and control profiles. npj Primary Care Respiratory Medicine. 27(1). 16089–16089. 8 indexed citations
8.
Hui, David, Aziah Ahmad Mahayiddin, Camilo C. Roa, et al.. (2011). Roflumilast in Asian patients with COPD: A randomised placebo-controlled trial. European Respiratory Journal. 38(Suppl 55). p3364–p3364. 1 indexed citations
9.
Guia, Teresita S. de, et al.. (2011). Burden of obstructive lung disease in a rural setting in the Philippines. Respirology. 16(7). 1111–1118. 46 indexed citations
10.
Hui, David S.C., et al.. (2011). Roflumilast in Asian patients with COPD: A randomized placebo‐controlled trial. Respirology. 16(8). 1249–1257. 28 indexed citations
11.
David-Wang, Aileen, et al.. (2006). THE MANAGEMENT OF CHRONIC COUGH IN A TERTIARY CARE CENTER: AN ASIAN PERSPECTIVE. CHEST Journal. 130(4). 199S–199S. 1 indexed citations
12.
Roa, Camilo C., et al.. (2003). The gastroprotective effect of tannins extracted from duhat (Syzygium cumini Skeels) bark on HCl/ethanol induced gastric mucosal injury in Sprague-Dawley rats.. PubMed. 29(3-4). 253–61. 63 indexed citations
13.
Roa, Camilo C., et al.. (2001). Enteral feeding in stable chronic obstructive pulmonary disease patients. Respirology. 6(1). 43–50. 14 indexed citations
14.
Roa, Camilo C., et al.. (2001). Enteral feeding in stable chronic obstructive pulmonary disease patients. Respirology. 6(1). 43–50. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026